Biotech innovators are facing a stark choice: they can either wait out a decade-long regulatory bottleneck to fix the food system, or they can use the same science to overhaul the beauty industry today. This calculated migration is driven by a major imbalance in how different industries are governed.

Developing clean food alternatives is a bureaucratic marathon. Meanwhile, the cosmetics sector offers a legitimate fast lane. By shifting focus to skincare, deep-tech startups can commercialize their discoveries, secure cash flow, and perfect production scales while their main food approval applications await a verdict.

The Market Opportunity of “Biotech Beauty”

The global bio-based cosmetics and personal care ingredients market is valued at approximately $5.84B in 2025 and is projected to reach $18.93B by 2035, a compound annual growth rate of 11.1%.

Within that, the cosmetics & personal care segment is the fastest-growing end-use category for precision fermentation ingredients, outpacing even food & beverage on a percentage growth basis, as brands race to replace petrochemical and animal-derived inputs with biotech alternatives.

Clean beauty has evolved into what the industry now calls “Biotech Beauty.” Precision fermentation and lab-grown actives allow manufacturers to produce rare compounds without the environmental footprint of traditional farming, delivering purity, stability, and consistency that wild-harvested natural extracts often can’t guarantee.

The Regulatory Gridlock: Food vs. Cosmetics

The core driver of this migration is systemic friction. Food and beauty safety architectures handle novel laboratory components in fundamentally opposite ways:

The Food Sector

  • In the US, the average time to approve a new direct food additive exceeds 6 years. The FDA’s GRAS notification process, while faster than a full food additive petition, still demands years of toxicological data, millions in research spend, and no guarantee of a “no questions” letter.
  • In the EU, a peer-reviewed analysis of 292 novel food applications submitted between 2018 and 2024 found the average time from submission to published EFSA opinion was 2.56 years, with the scientific evaluation phase alone ranging from 6 months to 4.5 years. One food regulation expert summarised it plainly: “Start-ups need funding to start the novel food process and keep going; they can only generate revenue if they have a product on the market.”

The Cosmetic Sector

  • In contrast, cosmetics in both the US and EU operate on a post-market regulatory model: no pre-market approval is required. Companies are responsible for safety, but the product can reach consumers and generate revenue, while the food dossier is still being reviewed.
  • The result: a company like FoodTech 500 alumni Clean Food Group received cosmetic approval for its yeast-derived oil in 2024, while its food-grade approval is still pending. ÄIO secured a €1M government grant specifically to bring its fermented fat to cosmetics first, ahead of its food launch.

In food, you wait years for permission. In cosmetics, you ask forgiveness if something goes wrong, and that asymmetry is reshaping where biotech startups choose to go to market first.

The Forward Fooding Alumni Data

Across the full FoodTech 500 alumni pool, 56 companies or 3.2% of the total, now have cosmetics, beauty, or personal care explicitly referenced in their company profile. That may sound modest, but it represents a meaningful and growing cluster within an ecosystem historically focused almost entirely on food systems.

The route these companies take to beauty is not uniform. Based on our data:

  • Fermentation-derived ingredients (precision or biomass fermentation): 15 companies,— the dominant new entrant pathway
  • Upcycled / circular (converting food or agri waste into beauty-grade ingredients): 17 companies, the most established pathway
  • AI-driven discovery (using computational platforms to identify bioactive molecules with dual food/beauty applications): 17 companies
  • Cell-cultivated ingredients (using cellular agriculture platforms to produce marine or animal-derived bioactives): 4 companies, small but high-profile
  • Algae/Marine-derived: 3 companies

Total disclosed funding raised across the 56 crossover companies since 2016 exceeds $491M, with a median raise of approximately $7.8M, suggesting most are at the scale-up phase rather than early-stage experiments.

In terms of where these companies originate, the UK (9 companies) and US (9) lead, followed by France (6), Germany (5), and Spain (5). Europe accounts for roughly two-thirds of the cluster, reflecting both the strength of the EU’s fermentation and biotech ecosystem and the pressure created by the EU’s stricter Novel Food regulation.

57% of the crossover companies are classified as scale-ups; 34% are startups. This is not a pivot of last resort, as most of these companies entered the beauty channel from a position of growth and not desperation.

The bulk of these companies were founded between 2016 and 2021, precisely the window when precision fermentation and the “better fats” narrative took hold in FoodTech. Many built their technology with food in mind, then discovered that the same molecule could reach consumers faster via beauty.

Case Study 1: Geltor

Courtesy: Geltor

Geltor, a mainstay on the Forward Fooding FoodTech 500, is perhaps the most successful example of this “cosmetics-first” strategy. Founded to create animal-free gelatin for the food industry, they quickly realized that the beauty industry’s appetite for “vegan collagen” was immediate and lucrative.

  • The Innovation: High-performance, biodesigned proteins created via precision fermentation.
  • The Move: They launched products like HumaColl21, the first human-type collagen for skincare, way back when the food side was still in the lab.
  • The Strategy: While they waited for the FDA “No Questions” letter for PrimaColl (their first biodesigned collagen cleared for food), they were already a household name in high-end cosmetics. They used the “easier” industry to fund the “harder” one.

Case Study 2: Nuritas – AI-Driven Beauty

Also a celebrated finalist on the 2025 FoodTech 500, Nuritas uses AI to identify bioactive peptides in plants. Their long-term dream is “Food as Medicine,” but their current commercial reality is deeply rooted in beauty.

  • The Innovation: An AI platform called “Magnifier” that discovers peptides that signal the skin to repair itself.
  • The Move: Massive partnerships with global ingredient giants, like BASF, to supply premium consumer skincare brands.
  • The Strategy: By applying their food-grade science to anti-aging skincare first, they proved the efficacy of their AI platform while navigating much simpler regulatory pathways than those required for medical-grade food supplements.

Case Study 3: Clean Food Group & ÄIO

One of the hottest topics recently is the rise of yeast-derived fats, with companies like the UK’s Clean Food Group and Estonia-based ÄIO racing to replace palm oil.

Case Study 4: IntegriCulture

Courtesy: IntegriCulture

Traditional “cultivated meat” companies are also joining the fray. Japan’s IntegriCulture is famous for lab-grown beef, but they’ve been making waves by using their “cell culture” tech to create skincare ingredients.

  • The Innovation: Using their “CulNet” system to grow animal cells without expensive growth factors.
  • The Move: Launching Cellament™, a cell-cultured serum for skin repair.
  • The Strategy: While cultivated meat faces significant regulatory lag and high costs, skincare ingredients can reach consumers much faster. This beauty-first approach has actually led the company toward profitability in 2026.

Case Study 5: Avant Meats

Hong Kong and Singapore-based Avant is globally recognized for its cultivated seafood technology designed to create alternative fish products. However, the intense regulatory drag on cultivated meat pushed them to tap into the lucrative $77.43B global anti-aging market.

  • The Innovation: The patented Zellulin® BioPlatform, which utilizes cultivated marine cells to isolate healthy cells just one time to grow cell-identical functional proteins.
  • The Move: Launching Zellulin® ZelluGEN™, an extracellular matrix (ECM) targeted regenerative peptide complex that instructs skin cells to generate more collagen, integrin, and fibrinogen.
  • The Strategy: While alternative seafood goes through lengthy regulatory phases, Avant successfully commercialized Zellulin® in cosmetics. In mid-2025, it achieved a historic milestone as the first non-food product to earn C-Label (V-Label) certification, solidifying its cruelty-free and sustainable status.

Conclusion: The Convergence of Food and Skin

This migration path benefits the entire biotechnology ecosystem, as crossover strategies give deep-tech startups a clear path through the capital-intensive AgriFoodTech sector. Selling high-margin cosmetic ingredients creates an organic revenue cushion, shielding founders from an over-reliance on venture capital, while they navigate agricultural safety reviews.

Simultaneously, consumers gain access to traceable, animal-free, and high-performance products. As the boundaries between systemic nutrition and topical care continue to fade, it becomes clear that when a biotech lab proves a novel molecule is safe enough to be absorbed by human skin, it is only a matter of time before that same technology transforms what we put on our plates.

 

Forward Fooding is the world’s first collaborative platform for the Food & Beverage industry via FoodTech Data Intelligence and Corporate-Startup Collaboration – Learn more about our Consultancy and Scouting Services and our Startup Network.